Dicot Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-80.2	-57.7	-44.16	-31.76	-27.17	Upgrade
Depreciation & Amortization	-	0.01	0.01	0.01	0.01	Upgrade
Other Operating Activities	0.3	0.03	-	-	-	Upgrade
Change in Accounts Receivable	-3.5	-2.02	-1.32	-0.07	-0.16	Upgrade
Change in Inventory	-2.6	-1.99	-1.91	-1.49	-	Upgrade
Change in Accounts Payable	-	2.3	1.12	0.84	1.09	Upgrade
Change in Other Net Operating Assets	0.2	0.5	1.03	2.75	0.38	Upgrade
Operating Cash Flow	-85.8	-58.87	-45.23	-29.71	-25.87	Upgrade
Issuance of Common Stock	43.8	144.18	97.26	9.92	40.42	Upgrade
Other Financing Activities	-2.2	-19.24	-14.07	-1.16	-4.56	Upgrade
Financing Cash Flow	41.6	124.95	83.19	8.76	35.87	Upgrade
Net Cash Flow	-44.2	66.08	37.96	-20.95	10	Upgrade
Free Cash Flow	-85.8	-58.87	-45.23	-29.71	-25.87	Upgrade
Free Cash Flow Per Share	-0.04	-0.05	-0.09	-0.24	-0.40	Upgrade
Levered Free Cash Flow	-57.58	-38.26	-29.26	-17.86	-15.72	Upgrade
Unlevered Free Cash Flow	-57.58	-38.25	-29.22	-17.83	-15.72	Upgrade
Change in Working Capital	-5.9	-1.21	-1.08	2.03	1.3	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.